Activation of EMT in breast carcinoma cell lines leads to the augmentation of TF expression, a phenomenon reversed by the silencing of ZEB1 (Zinc finger E-box-binding homeobox 1), a master regulatory factor of the EMT [18]. Here, TF is linked to breast carcinoma.